Accelerating Alzheimer’s Prevention: A Global Imperative

Developed in collaboration with world-leading experts across academia, government and industry, our latest paper dives into the urgent global challenge of Alzheimer’s disease and highlights the groundbreaking potential of preventative interventions. Learn about the scientific breakthroughs, including the rise of disease-modifying therapies, that are paving the way for innovative solutions.

Accelerating Alzheimer’s Prevention: A Global Imperative | December 2024

The Case for Regulatory Approval of Amyloid Lowering Immunotherapies in Alzheimer’s Disease | November 2024

Access the full paper here.

How DAC and CEOi Are Accelerating the Alzheimer's Vaccine Field | Davos 2024

The Potential Impact of an Alzheimer's Active Immunotherapy | Davos 2024

Unveiling a Path to Market for Alzheimer's Vaccines | Davos 2024

The Value of Blood-Based Biomarkers for Alzheimer's Vaccines | Davos 2024